Senator Investment Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-90,000
| Closed | -$7.74M | – | 67 |
|
|
2024
Q4 | $7.74M | Sell |
90,000
-10,000
| -10% | -$860K | 0.23% | 50 |
|
|
2024
Q3 | $11.9M | Sell |
100,000
-45,000
| -31% | -$5.36M | 0.57% | 50 |
|
|
2024
Q2 | $20.7M | Sell |
145,000
-5,000
| -3% | -$714K | 1.01% | 38 |
|
|
2024
Q1 | $19.3M | Buy |
150,000
+140,000
| +1,400% | +$18M | 0.88% | 37 |
|
|
2023
Q4 | $1.03M | Buy |
+10,000
| New | +$1.03M | 0.04% | 62 |
|
|
2023
Q2 | – | Sell |
-850,000
| Closed | -$67.6M | – | 60 |
|
|
2023
Q1 | $67.6M | Buy |
850,000
+450,000
| +113% | +$35.8M | 3.69% | 10 |
|
|
2022
Q4 | $27.1M | Buy |
+400,000
| New | +$27.1M | 2.44% | 12 |
|